Teriparatide-denosumab combo shows promise for osteoporosis

05/15/2013 | HealthDay News

Combining teriparatide and denosumab was more effective than using the drugs alone in increasing bone density in postmenopausal women with osteoporosis, a small study found. The combination also was more effective than any drugs on the market today, the study author said. The findings appeared online in The Lancet.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC